OBJECTIVE: @entity2332 ( @entity2332 ) is recommended to improve survival and neurologic prognosis in @entity1164 ( @entity1164 ) survivors. There are few data aboutglycemic levels in these @entity1 . The aim of this study is to evaluate the glycemic control using a specific protocol in this group ofpeople. METHOD: A retrospective analysis of the @entity1 receiving @entity2332 in our institution, between January 2010 and March 2013,. was performed. Baseline characteristics, in-hospital prognosis and glycemic levels during different stages of the @entity2332 were analyzed. RESULTS: From a total of 55 @entity1 suffering a @entity1164 , 49 @entity1 underwent @entity2332 and received a specific insulin protocol. The mean age was 57.5    12.8 years, the main cause of @entity1164 was @entity63 (76%) and @entity2224 was the most frequent first rhythm detected (55%). Regarding glycemic alterations as each stage of @entity2332 , a high rate of glycemic alteration was observed in the induction stage, decreasing after starting the insulin protocol (induction stage: 95.9%; maintenance stage: 89.8%; rewarming stage: 69.4%; p = 0.001). With respectto clinicresults, there were low rates of severe @entity4053 (12%), in-hospital mortality (20%) and @entity75 (27%), with a high rate of @entity281 (75%). CONCLUSIONS: The implementation of a specific insulin protocol in @entity1 receiving @entity2332 contributes to improve the blood @entity413 levels. Further studies are needed to evaluate the clinical impact of these protocols in this group ofpatients.

[OPTIMIZATION OF GLUCOSE METABOLISM IN XXXX UNDERGOING THERAPEUTIC HYPOTHERMIA AFTER SUDDEN CARDIAC ARREST].

@entity1164 :: ('MESH:D016757', 'Disease') :: ['SCA', 'sudden cardiac arrest'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity63 :: ('MESH:D007511', 'Disease') :: ['ischemic'] @entity75 :: ('MESH:D001927', 'Disease') :: ['anoxic encephalopathy'] @entity4053 :: ('MESH:D007003', 'Disease') :: ['hypoglycemia'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infections'] @entity2224 :: ('MESH:D014693', 'Disease') :: ['ventricular fibrillation'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose'] @entity2332 :: ('MESH:D007035', 'Disease') :: ['Therapeutic hypothermia', 'TH']
@entity1 :: (9606,Species) :: ['PATIENTS']
